RxDoctor Payments Data

Kodi Bone, PA

Physician Assistant · Ludington, MINPI 1184886012

Payments from drug & device makers

$7,540in general payments, 2019–2025

Across 338 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$474
  • Merck$463
  • Genentech USA, Inc.$443
  • AstraZeneca$441
  • Takeda Pharmaceuticals U.S.A., Inc.$402
  • Incyte Corporation$377
  • plus $5K from 53 others

What the payments were for

  • Food & beverage$7,25296%
  • Education$2884%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis25$474
Merck18$463
Genentech USA, Inc.23$443
AstraZeneca20$441
Takeda Pharmaceuticals U.S.A., Inc.14$402
Incyte Corporation14$377
Eisai Inc.12$298
Jazz Pharmaceuticals Inc.10$279
Pfizer15$257
Daiichi Sankyo Inc.11$253
AbbVie10$221
Johnson & Johnson11$214
Seagen Inc.8$209
Lilly USA, LLC9$201
Sanofi7$185
Bristol Myers Squibb9$168
Karyopharm Therapeutics Inc.8$167
Regeneron Healthcare Solutions, Inc.6$159
GSK7$152
Ipsen Biopharmaceuticals, Inc6$142
Gilead(2 entities)7$137
Beigene USA, Inc.5$120
Amneal Pharmaceuticals LLC5$111
ADC Therapeutics America, Inc.4$99
Legend Biotech USA Inc.3$94
E.r. Squibb & Sons, L.L.C.2$89
Pharmaessentia USA Corporation4$80
Tersera Therapeutics LLC4$78
Puma Biotechnology, Inc.4$73
EMD Serono, Inc.4$73
Amgen4$69
Beone Medicines USA, Inc.2$67
Astellas Pharma US Inc3$67
Rigel Pharmaceuticals, Inc.3$61
Sobi, Inc3$58
Sumitomo Pharma America, Inc.3$57
Deciphera Pharmaceuticals Inc.3$54
Genmab U.S., Inc.3$53
Adaptive Biotechnologies Corporation2$48
Springworks Therapeutics, Inc.2$46
Agios Pharmaceuticals, Inc.2$46
Coherus Oncology, Inc.2$43
Syndax Pharmaceuticals, Inc.2$42
Acrotech Biopharma Inc.2$35
Sun Pharmaceutical Industries Inc.1$32
Stemline Therapeutics Inc.2$31
Pharmacyclics LLC, An Abbvie Company2$30
Geron Corporation1$28
CTI Biopharma Corp.1$27
Progenics Pharmaceuticals, Inc.1$25
Blueprint Medicines Corporation1$22
Tempus AI, Inc1$22
G1 Therapeutics, Inc.1$20
Aadi Bioscience, Inc.1$20
Myovant Sciences Inc.1$19
Exelixis Inc.1$18
Caris MPI, Inc.1$15
AVEO Pharmaceuticals, Inc.1$14
Foundation Medicine, Inc.1$12

How this compares

$7,540 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$114,847
Medicare patients
134
Services billed
4,890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxyurea19$686

Paid to pharmacies, not to this prescriber.

Other physician assistant in Ludington

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →